Bunge Global (BG)

NYSE Consumer Staples Agricultural Products & Services S&P 500
$99.10
+0.56 (+0.57%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Not scheduled yet
No report date announced in the next three weeks.
Consensus EPS estimate
—
Shown once a date is announced.
Trailing 12-month EPS
$5.95
Diluted, last four reported quarters

Earnings surprise history

reported EPS vs consensus
ReportedQuarterEPS estimateReported EPSSurprise
Oct 29, 2026Sep/2026$2.45$2.56+4.5%

Our record of BG's reports since we began tracking; it grows each quarter.

Latest results, in brief

All BG 8-K briefs →
Oct 29, 9:00 AM ET

Bunge Q3 GAAP EPS rises to $1.64 from $0.86; full-year adjusted EPS outlook held

Positive earnings 2.02

Bunge reported third quarter 2026 results, with net income attributable to Bunge of $318 million, up from $166 million a year earlier, and net sales of $23,804 million versus $22,155 million. The company kept its full-year 2026 adjusted EPS outlook at $9.25 to $9.75, while expecting slightly lower Soybean Processing and Refining results and lower Tropical Oils and Specialty Ingredients results than previously outlined, which matters to shareholders because higher profit came with an unchanged earnings target.

  • Q3 GAAP diluted EPS from continuing operations was $1.64 versus $0.86; adjusted EPS was $2.56 versus $2.27.
  • Nine-month adjusted EPS was $6.38 versus $5.56, while cash used for operating activities was $2,302 million versus $503 million.
  • Q3 included $82 million of charges tied to the announced sale of two sugarcane mills in Brazil.
  • Adjusted annual effective tax rate outlook is 23% to 25%; net interest expense outlook is $640 to $670 million.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Sep 2026$5.45B+24.7% $1.64+95.2% $318.00M5.8%
Jun 2026$4.93B+22.6% $3.47+33.0% $678.00M13.8%
Mar 2026$4.66B+27.2% $0.35-76.4% $68.00M1.5%
Dec 2025$4.89B+22.2% $0.49-88.8% $95.00M1.9%
Sep 2025$4.37B+12.9% $0.84-46.2% $166.00M3.8%
Jun 2025$4.02B+7.7% $2.61+443.8% $354.00M8.8%
Mar 2025$3.66B-7.1% $1.48-11.9% $201.00M5.5%
Dec 2024$4.00B-8.5% $4.36+4.3% $602.00M15.0%

From Bunge Global's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2025$16.94B+9.0% $4.91-38.5%4.8%
FY2024$15.55B-12.8% $7.99-46.3%7.3%
FY2023$17.83B-15.4% $14.87+41.5%12.6%
FY2022$21.07B+25.4% $10.51-22.9%7.6%
FY2021$16.81B— $13.64—12.4%

Frequently asked questions

When is Bunge Global's next earnings date?

Bunge Global has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.

What did Bunge Global earn last quarter?

For the quarter ended Sep 2026, Bunge Global reported diluted EPS of $1.64 (+95.2% year over year) on revenue of $5.45B (+24.7%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.